CDC’s Central Asia Regional (CAR) office works to strengthen public health systems in the region by focusing on strategic information, blood safety, injection safety, laboratory services, HIV/AIDS prevention for at-risk and vulnerable populations, and treatment and care services. CDC’s support includes:
The office helps build the capacity of prevention specialists through training and mentoring; by implementing evidence-based pilot programs; adopting new modes of service delivery and expanding prevention and related services for at-risk populations
The CAR also strengthens HIV treatment and care services by developing clinical guidelines for screening and managing HIV infection; enhancing diagnosis of HIV infection and co-infection and continues to work to improve national monitoring and evaluation systems (M&E) as well as develop strategic laboratory plans and accreditation activities.
Key Activities and Accomplishments
- Conducted several assessments of HIV integrated bio-behavioral surveillance (IBBS); HIV care and treatment services; and Medication Assisted Treatment (MAT) services in Kazakhstan, Kyrgyzstan, and Tajikistan
- Facilitated nationwide implementation of an electronic HIV case monitoring system (EHCMS) in Kazakhstan, Kyrgyzstan and Tajikistan and supported routine data quality assurance and audit activities.
- Supported the opening of four MAT sites in Kyrgyzstan, including in the penitentiary system where people who inject drugs receive integrated HIV/TB/MAT prevention and treatment services.
- Supported the launch of two Mobile Trust Points in Kyrgyzstan—the first program in the region that sought to connect people who inject drugs to basic HIV prevention services.
More information and data regarding TB in Kazakhstan is available online at WHO’s TB Country Profilesexternal icon.
More information about CDC’s global health work in Kazakhstan is available online at CDC in Kazakhstan.